Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
- 2004 -
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
January 2004 - 5 products
IP
CI
Copaxone 20mg/ml
28 Fertigspritze(n)
778.94
855.90
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
L
IP
CI
Copaxone 40mg/ml
12
737.70
805.10
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
IP
CI
Copaxone 40mg/ml
3
PR
PR
k.A.
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B
FB
G
CI
H
Calvakehl D3
10 ml
PR
PR
k.A.
ebi-pharm ag
D
FB
G
CI
H
Calvakehl D3
30 ml
PR
PR
k.A.
ebi-pharm ag
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home